![Overcoming Mutagenicity and Ion Channel Activity: Optimization of Selective Spleen Tyrosine Kinase Inhibitors]()
Overcoming Mutagenicity and Ion Channel Activity: Optimization of Selective Spleen Tyrosine Kinase InhibitorsEllis, J. Michael; Altman, Michael D.; Bass, Alan; Butcher, John W.; Byford, Alan J.; Donofrio, Anthony; Galloway, Sheila; Haidle, Andrew M.; Jewell, James; Kelly, Nancy; Leccese, Erica K.; Lee, Sandra; Maddess, Matthew; Miller, J. Richard; Moy, Lily Y.; Osimboni, Ekundayo; Otte, Ryan D.; Reddy, M. Vijay; Spencer, Kerrie; Sun, Binyuan; Vincent, Stella H.; Ward, Gwendolyn J.; Woo, Grace H. C.; Yang, Chiming; Houshyar, Hani; Northrup, Alan B. · Journal of Medicinal Chemistry · 2015